Finally, a Proven, Minimally Invasive Approach to BPH

Teleflex

Benign prostatic hyperplasia (BPH) affects millions of men, and many patients seek a minimally invasive alternative to major surgical treatment or to medications, which are discontinued by a third of BPH patients due to bothersome side effects and insufficient relief. Teleflexs FDA-approved UroLift System for Prostatic Urethral Lift is that alternative: a minimally invasive approach to BPH, performed in outpatient or inpatient settings under general or local anesthesia. The UroLift System consists of the UroLift Delivery Device, inserted transurethrally, and the UroLift Implants, permanent implants deployed by the delivery device to hold obstructing prostatic lobes apart. Learn more about the UroLift System for BPH relief.

For more information, visit UroLift.com/info or click on "Learn More" below.